Jagtar Singh

Mr. Jagtar Singh

Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Mohali, India
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2023 in Journal of Polymer Science
Verified
Journal Article
Closed access
JSJagtar Singh
Jagtar Singh
PNPallavi Nayak
Pallavi Nayak

27 December 2022 in C
Verified
Journal Article
Open access
PDF file
JSJagtar Singh
Jagtar Singh
PNPallavi Nayak
Pallavi Nayak
GSGurdeep Singh
Gurdeep Singh
MKMADHUSMRUTI KHANDAI
MADHUSMRUTI KHANDAI
RSRashmi Ranjan Sarangi
Rashmi Ranjan Sarangi
MKMihir Kumar Kar
Mihir Kumar Kar
Recent developments in nanotechnology and process chemistry have expanded the scope of nanostructures to the biomedical field. The ability of nanostructures to precisely deliver drugs to the target site not only reduces the amount of drug needed but also reduces systemic adverse effects. Carbon nanostructures gained traction in pharmaceutical technology in the last decade due to their high stability, ease of synthesis, tunable surface chemistry, and biocompatibility. Fullerene, nanotubes, nanodiamonds, nanodots, and nanoribbons are among the major carbon nanostructures that have been extensively studied for applications in tissue engineering, biosensing, bioimaging, theranostics, drug delivery, and gene therapy. Due to the fluorescent properties of functionalized nanostructures, they have been extensively studied for use as probes in cellular imaging. Moreover, these nanostructures are promising candidates for delivering drugs to the brain, bones, and deep-seated tumors. Still, research gaps need to be addressed regarding the toxicity of these materials in animals as well as humans. This review highlights the physicochemical properties of carbon nanostructures and their categories, methods of synthesis, various techniques for surface functionalization, major biomedical applications, mechanisms involving the cellular uptake of nanostructures, pharmacokinetic considerations, recent patents involving carbon-based nanostructures in the biomedical field, major challenges, and future perspectives.

11 February 2025 in Inflammopharmacology
Verified
Journal Article
Closed access
PDF file
RSRajesh Sandu
Rajesh Sandu
JSJagtar Singh
Jagtar Singh

13 September 2022 in Research Square
Verified
Preprint
Open access
PDF file
JSJagtar Singh
Jagtar Singh
MSMohit Sharma
Mohit Sharma
TJThakur Prava Jyoti
Thakur Prava Jyoti
RKRitik Kaundal
Ritik Kaundal
RBRitika Behl
Ritika Behl
STSuryadev Tripathi
Suryadev Tripathi
Herbal medicines and food products have extensively been looked upon for decades due to their biocompatible nature and the least adverse effects. At the same pace, plant-based cosmetics and toiletries are capturing the market due to their eco-friendly nature and compatibility with human skin. The marketed soaps and hand washes are based on toxic fatty acid salts, surfactants, and perfumes that are not only harmful to the skin but to the environment as well. The commonly used surfactant in soaps and hand washes, sodium lauryl sulfate makes the skin dry and sensitive. Moreover, the water getting polluted by SLS when entering the water bodies, makes the aquatic life vulnerable. So, it becomes important to formulate such hand washes that are biocompatible, without compromising their cleansing action and anti-microbial properties. This piece of work explores the formulation of an anti-bacterial hand wash having a good cleansing action to serve the purpose of maintaining personal hygiene in a biocompatible and eco-friendly way.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
JSJagtar Singh
Jagtar Singh
MSMohit Sharma
Mohit Sharma
AMAmit Mittal
Amit Mittal
PUPuneet Utreja
Puneet Utreja
HSHarmeet Singh
Harmeet Singh
SKShubham Kumar
Shubham Kumar
Background: Mesalamine, an anti-inflammatory drug, is a first-line drug used in the treatment of ulcerative colitis. The premature release of drugs associated with the marketed formulations causes side effects like gastric trouble, nausea, vomiting, diarrhea, etc. These systemic side effects can be minimized by ensuring the site-specific and local delivery of the drug to the colon. Also, the pharmacotherapeutic role of the gut microbiome has a significant impact on the remission of ulcerative colitis. These probiotics being acid-labile necessitates developing a gastro-resistant formulation that can enhance the delivery of viable cells at the site of inflammation. Aim and Objectives: The present study was aimed at developing colon-targeted hydrogel beads loaded with mesalamine and Bifidobacterium bifidum for their synergistic role in the long-term management of ulcerative colitis. This co-encapsulated formulation is target specific, increases the residence time of the drug in the colon due to mucoadhesiveness, sustains the release profile, and significantly enhances the cell viability for better colonization in the colonic mucosa. Methods: The mesalamine and Bifidobacterium bifidum loaded hydrogel beads were prepared by ionotropic gelation. The effect of single and dual cross-linking approach on various formulation characteristics was studied. Eudragit ® S100 gastro-resistant capsules were prepared in standard size 00. The optimised formulation was filled inside the Eudragit ® capsules. Results There was no potential interaction between the drug and the polymer, confirmed through FTIR analysis. The mean particle size, angle of repose, percentage yield, drug entrapment efficiency, percentage drug loading, cell entrapment efficiency, swelling index, mucoadhesiveness, disintegration time (for capsules), and in vitro dissolution profile of the optimized formulation was found to be 457.3±12.5µm, 25.51±0.57, 98.75±0.6%, 98.4±2.56%, 49.8±0.64%, 81.03±2.57%, 10.41±2.02, 83.1±3.62, 12 minutes 46 seconds and 99.85±1.07% (in 20 hours) respectively. All the values were statistically significant at p<0.05. Conclusion: The results strongly supported the aim of the study that prepared hydrogel beads can release mesalamine at colonic pH in a sustained manner while significantly increasing the delivery of viable cells to the colon.

22 September 2026 in RSC Pharmaceutics
Verified
Journal Article
Open access
GKGitika Kumari
Gitika Kumari
SKSourabh Kundu
Sourabh Kundu
JSJagtar Singh
Jagtar Singh
SJSneha Jakhotia
Sneha Jakhotia
SSSaurabh Srivastava
Saurabh Srivastava
DSDadi A Srinivasarao
Dadi A Srinivasarao
Exploration of polymeric nanoparticles to improve the ocular bioavailability of hydrophobic molecules; demonstration of the importance of nanoparticle size for ophthalmic drug delivery; development of a non-invasive nanoparticulate delivery system.